Abstract
Two billion people, nearly one-third of the population worldwide, are infected by M. tuberculosis. Since 2008, the number of foreign TB cases in Italy has overtaken native cases. Even though TB prevalently affects elderly Italian natives, the diagnosis of the disease in these subjects is difficult and frequently delayed because of the low index of suspicion due to loss of clinical experience. Moreover, the large use of TNF inhibitors has created a new risk group for the disease, highlighting the need for tougher screening practices to reduce new cases of severe TB. Immigration from high-incidence countries like Romania has increased the number of cases of multi-drug resistant TB. These cases are usually difficult to treat because of fewer treatment options and also difficulty in managing patients with adverse socioeconomic conditions such as homelessness. It is mandatory that young doctors acquire experience in the diagnosis and treatment of TB, a disease that is not so infrequent as it was a decade or two ago.
Similar content being viewed by others
References
Tuberculosis. World Health Organization Fact sheet N°104 March 2012. http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 1 Jun 2012
WHO Report 2011. Global tuberculosis control. http://www.who.int/tb/data. Accessed 1 Jun 2012
Rapporto Tubercolosi 2008 in Italia. Italian Ministry of Health. http://www.salute.gov.it (in Italian). Accessed 1 Jun 2012
Fattorini L, Mustazzolu A, Piccaro G et al (2012) Drug-resistant tuberculosis among foreign-born persons in Italy. Eur Resp J 40:1–4
Das SK, Mukherjee RS, Ghosh IN (2007) A study of pulmonary tuberculosis in the elderly. J Indian Med Assoc 105(8):432, 436, 438–439
Gagliotti C, Resi D, Moro ML (2006) Delay in the diagnosis of pulmonary TB in a changing demographic scenario. Int J Tuberc Lung Dis 10(3):305–309
Ginsburg AS, Woolwine SC, Hooper N et al (2003) The rapid development of fluoroquinolone resistance in M. tuberculosis. N Engl J Med 349(20):1977–1978
Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE (2012) Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability. J Immunol 188(7):3169–3178 (Epub 2012 Feb 29)
TB control guidelines 2010. Italian ministry of Health. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1661_allegato.pdf (in Italian). Accessed 1 Jun 2012
Zhao Y, Xu S, Wang L et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23):2161–2170
Sotgiu G, Centis R, D’Ambrosio L (2012) Efficacy, safety and tolerability of Linezolid containing regimens in treating MDR-TB and XDR-TB: systemic review and metanalysis. Eur Respir J [Epub ahead of print]
Migliori GB, Zellweger JP, Abubakar I et al (2012) European union standards for tuberculosis care. Eur Respir J 39(4):807–819
Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H et al (2012) Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 366(23):2151–2160
Diacon AH, Donald PR, Pym A et al (2012) Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother 56(6):3271–3276 (Epub 2012 Mar 5)
Kempker RR, Vashakidze S, Solomonia N et al (2012) Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12(2):157–166
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Lorenzo, S., Tiberi, S. Tuberculosis a re-emerging disease. Intern Emerg Med 7 (Suppl 3), 185–187 (2012). https://doi.org/10.1007/s11739-012-0822-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0822-9